Aesica, a UK-headquartered contract manufacturer of APIs, formulated products and custom synthesis solutions, has appointed a new site manager for its Cramlington, Northumberland facility.
David Leaver has been promoted from the position of operations manager at the Aesica site, which is responsible for the firm’s API production. He will lead a team of more than 130 people.
Leaver has been with Aesica since its inception in 2004, having joined from BASF, and has been pivotal to its growth. In 2008 he moved to the company’s site in Queenborough, Kent, to oversee the transition from Abbott to Aesica and returned to Cramlington in 2010 as operations manager. He brings 20 years’ experience in the pharma industry to his new role.
Kevin Cook, managing director of Aesica’s API division, said: ‘Having been part of the Cramlington site since the very beginning, David has grown with the company as it has expanded globally and adapted to the changing API landscape. There’s no-one better placed to lead our API facility.’
The Cramlington site has recently passed its statutory Medicines and Healthcare products Regulatory Agency (MRHA) inspection, reaffirming its compliance with the highest quality and regulatory standards.
Aesica appoints new site manager at Cramlington
David Leaver is promoted from operations manager
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
How contract manufacturers can bridge the innovation–commercialisation divide
With R&D budgets under pressure, the pharmaceutical industry would do well to look to the contract manufacturing sector for innovative approaches and technologies that could make production more effective and efficient, and achieve more with finite resources